MedTrace Logo

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

NCT01221805 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2040

Last updated 2016-08-05

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the ability of STA® Liatest® D-Di combined with a clinical pretest probability (PTP) to safely exclude pulmonary embolism (PE) or Deep Venous Thrombosis (DVT) in a 3 month follow-up.

Conditions

Sponsors & Collaborators

  • University Hospital, Grenoble

    collaborator OTHER

  • Diagnostica Stago

    lead INDUSTRY

Principal Investigators

  • GILLES PERNOD, MD PhD · University Hospital, Grenoble

Eligibility

Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2016-03-31
Completion
2016-04-30

Countries

  • United States
  • Canada
  • France
  • Italy
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01221805 on ClinicalTrials.gov